Patents Assigned to SYNT:EM, a corporation of France
  • Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases
    Publication number: 20050159360
    Abstract: A pharmaceutical composition including at least one therapeutic molecule effective for treating lung cancers or pulmonary diseases; and at least one peptide vector that augments bioavailability of the molecule in a patient's lungs selected from the group consisting of Ala-Trp-Ser-Phe-Arg-Val-Ser-Tyr-Arg-Gly-Ile-Ser-Tyr-Arg-Arg-Ser-Arg (SynB4) (SEQ ID No. 1), and Arg-GLy-Gly-Arg-Leu-Ser-Tyr-Ser-Cit-Cit-Cit-Phe-Ser-Thr-Ser-Thr-Gly-Arg (SynB6) (SEQ ID No. 2).
    Type: Application
    Filed: December 17, 2004
    Publication date: July 21, 2005
    Applicant: SYNT:EM, a corporation of France
    Inventors: Jamal Temsamani, Anthony Rees, Christophe Rousselle